← FDA Drug Approvals (Drugs@FDA)

BUTALBITAL, ACETAMINOPHEN AND CAFFEINE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: LANNETT CO INC · Approved 2019-12-17

Drug application

FDA Application #

ANDA212083

Application type

Abbreviated New Drug Application (Generic)

Brand name

BUTALBITAL, ACETAMINOPHEN AND CAFFEINE

Generic name

BUTALBITAL, ACETAMINOPHEN AND CAFFEINE

Active ingredients

ACETAMINOPHEN; BUTALBITAL; CAFFEINE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

LANNETT CO INC

Manufacturer

Lannett Company, Inc.

First approval

2019-12-17

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown